A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants
Status:
Terminated
Trial end date:
2020-05-22
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effects on cardiac repolarization of high-dose
padsevonil (PSL) in comparison to placebo in healthy study participants.
Phase:
Phase 1
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.
Treatments:
Moxifloxacin Norgestimate, ethinyl estradiol drug combination